SpaceX (SPCX) Stock: Institutional Buying Grows as Starship Test 14 Nears

03-Sep-2026 CoinCentral

TLDR

  • SpaceX filed FCC paperwork for Starship test 14, with an operation start date of September 15.
  • The filing referenced an “orbital second stage,” suggesting the first orbital insertion attempt for Starship’s upper stage.
  • SpaceX stock opened at $140.71, down 1.1%, with a market cap of $1.84 trillion.
  • Quarterly revenue hit $7.81 billion, up 91.9% year over year, beating earnings expectations.
  • Analysts hold a consensus “Moderate Buy” rating with a target price of $221.20.

SpaceX stock opened at $140.71 on Thursday, down 1.1%, just above its June IPO price of $135. The company carries a market cap of $1.84 trillion.


SPCX Stock Card
Space Exploration Technologies Corp., SPCX

The latest catalyst is a fresh FCC filing from SpaceX related to Starship test 14. The filing lists an operation start date of September 15 and references an “orbital second stage,” pointing to a first orbital insertion attempt for Starship’s upper stage.

Starship test 13 launched in late July and logged several milestones, including the deployment of 20 Starlink V3 satellites.

The Starlink broadband business now has over 12 million subscribers. In the most recent quarter, the connectivity segment generated roughly $1.66 billion in operating profit.

SpaceX reported quarterly revenue of $7.81 billion, up 91.9% year over year. The company posted a loss of $0.09 per share, beating the analyst consensus estimate of a $0.26 loss by $0.17.

Institutional Investors Keep Buying

Carter Financial Group opened a new position in SpaceX during Q2, picking up 7,809 shares valued at approximately $1.33 million. Several smaller firms also initiated positions, including Atwood & Palmer, Marquette Asset Management, and Orion Capital Management.

SpaceX has a 52-week range of $104.83 to $225.64 and a 50-day moving average of $136.33.

On the analyst side, Cantor Fitzgerald holds an “overweight” rating with a $246 price target. Deutsche Bank has a “buy” rating and a $255 target. Arete Research set the highest target on the street at $450. The consensus sits at “Moderate Buy” with an average target of $221.20.

Oppenheimer recently raised its target to $280, citing faster-than-expected AI usage and expanding infrastructure. Bernstein set a $248 target and expects AI revenue could nearly quintuple in 2027.

Risks Still on the Table

Not everything is smooth. SpaceX reportedly reshuffled its data-center leadership after reliability issues at facilities in Tennessee and Mississippi. A September 30 deadline looms for Google’s reported $920 million-per-month computing agreement.

SpaceX’s AI unit reportedly accounted for the bulk of quarterly capital spending. The company’s valuation leaves little margin for error.

Dependence on Elon Musk remains a key governance concern for some investors.

On a more positive note, Google and Anthropic have reportedly turned to SpaceX for AI computing capacity as electricity and data-center space become constrained on the ground.

The Pentagon’s authorization of Starshield AI’s Grok for government use also adds to SpaceX’s defense and orbital computing story.

SpaceX hopes to carry commercial payloads on Starships by the end of 2026. Analysts anticipate a full-year loss of $0.15 per share for the current fiscal year.

The post SpaceX (SPCX) Stock: Institutional Buying Grows as Starship Test 14 Nears appeared first on CoinCentral.

Also read: Datadog (DDOG) Stock Rises 5% as Snowflake Earnings Beat Fuels AI Cloud Rally
WHAT'S YOUR OPINION?
Related News